CCChristi D. Cook

Christi D. Cook

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christi D. Cook has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Linda G. Griffith

    Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

    3 shared publications
  • Douglas A. Lauffenburger

    Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

    2 shared publications
  • Julia P. Papps

    Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

    2 shared publications
  • Linda Stockdale

    Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

    2 shared publications
  • Abby S. Hill

    Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

    1 shared publication
  • Andrew T. Krueger

    †Department of Biological Engineering, ‡Department of Chemical Engineering, §Center for Gynepathology Research, ∥Department of Chemistry and ⊥̂Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts United States

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies

    by Collin D. Edington, Wen Li Kelly Chen, Emily Geishecker, Timothy Kassis, Luis R. Soenksen, Brij M. Bhushan, Duncan Freake, Jared Kirschner, Christian Maass, Nikolaos Tsamandouras, et al.

    Microphysiological systems (MPSs) are in vitro models that capture facets of in vivo organ function through use of specialized culture microenvironments, including 3D matrices and microperfusion. Here, we report an approach to co-culture multiple different MPSs linked together physiologically on re-useable, open-system microfluidic platforms that are compatible with the quantitative study of a range of compounds, including lipophilic drugs. We describe three different platform designs – “4-way”, “7-way”, and “10-way” – each accommodating a mixing chamber and up to 4, 7, or 10 MPSs. Platforms accommodate multiple different MPS flow configurations, each with internal re-circulation to enhance molecular exchange, and feature on-board pneumatically-driven pumps with independently programmable flow rates to provide precise control over both intra- and inter-MPS flow partitioning and drug distribution. We first developed a 4-MPS system, showing accurate prediction of secreted liver protein distribution and 2-week maintenance of phenotypic markers. We then developed 7-MPS and 10-MPS platforms, demonstrating reliable, robust operation and maintenance of MPS phenotypic function for 3 weeks (7-way) and 4 weeks (10-way) of continuous interaction, as well as PK analysis of diclofenac metabolism. This study illustrates several generalizable design and operational principles for implementing multi-MPS “physiome-on-a-chip” approaches in drug discovery.


  • Open Access

    Local remodeling of synthetic extracellular matrix microenvironments by co-cultured endometrial epithelial and stromal cells enables long-term dynamic physiological function

    by Christi D. Cook, Abby S. Hill, Margaret Guo, Linda Stockdale, Julia P. Papps, Keith B. Isaacson, Douglas A. Lauffenburger, Linda G. Griffith

    Synthetic 3D matrix binds cell-secreted matrix and mimics endometrial epithelial–stromal tissue architecture, hormone responsiveness, and cytokine production.


  • Open Access

    Covalent Modification of Synthetic Hydrogels with Bioactive Proteins via Sortase-Mediated Ligation

    by Elena Cambria, Kasper Renggli, Caroline C. Ahrens, Christi D. Cook, Carsten Kroll, Andrew T. Krueger, Barbara Imperiali, Linda G. Griffith

    Synthetic extracellular matrices are widely used in regenerative medicine and as tools in building in vitro physiological culture models. Synthetic hydrogels display advantageous physical properties, but are challenging to modify with large peptides or proteins. Here, a facile, mild enzymatic postgrafting approach is presented. Sortase-mediated ligation was used to conjugate human epidermal growth factor fused to a GGG ligation motif (GGG-EGF) to poly(ethylene glycol) (PEG) hydrogels containing the sortase LPRTG substrate. The reversibility of the sortase reaction was then exploited to cleave tethered EGF from the hydrogels for analysis. Analyses of the reaction supernatant and the postligation hydrogels showed that the amount of tethered EGF increases with increasing LPRTG in the hydrogel or GGG-EGF in the supernatant. Sortase-tethered EGF was biologically active, as demonstrated by stimulation of DNA synthesis in primary human hepatocytes and endometrial epithelial cells. The simplicity, specificity, and reversibility of sortase-mediated ligation and cleavage reactions make it an attractive approach for modification of hydrogels.